Could a simple local treatment cut blood transfusions in hip fracture surgery?

NCT ID NCT06289478

Recruiting now Disease control Sponsor: King Chulalongkorn Memorial Hospital Source: ClinicalTrials.gov ↗

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This trial tests whether applying tranexamic acid (TXA) directly to the surgical site during hip fracture surgery can reduce the need for blood transfusions in elderly patients. Participants receive TXA either as an injection through a drain tube or as a topical soak, compared to standard care. The study focuses on patients over 60 with femoral neck fractures undergoing a specific type of hip replacement. The goal is to see if this local approach is both effective and safe.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Tranexamic acid (TXA) applied locally during surgery, either as an injection through a drain tube or as a topical soak
What this could lead to: If effective, this could reduce the need for blood transfusions and improve recovery in elderly hip fracture patients.
What could go wrong: The trial is small and early, and results may not apply broadly. Risks include wound complications, blood clots, or other adverse events.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEMORAL NECK FRACTURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

femoral neck fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FEMORAL NECK FRACTURE

Contacts and locations

Locations

Faculty of Medicine
NOT_YET_RECRUITING

Bangkok, Bangkok, 10330, Thailand
Faculty of Medicine, King Chulalongkorn Memorial Hospital
RECRUITING

Bangkok, Bangkok, 10330, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.